Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Radiomics and radiogenomics of primary liver cancers

Woo Kyoung Jeong, Neema Jamshidi, Ely Richard Felker, Steven Satish Raman, David Shinkuo Lu

Clin Mol Hepatol. 2019;25(1):21-29. Published online November 16, 2018

DOI: https://doi.org/10.3350/cmh.2018.1007

View: 12564 Download: 408 Web of Science: 44 Crossref: 48

Editorial

Clinical implication of hepatic volumetry for living donor liver transplantation

Woo Kyoung Jeong

Clin Mol Hepatol. 2018;24(1):51-53. Published online March 22, 2018

DOI: https://doi.org/10.3350/cmh.2018.1003

View: 6495 Download: 93 Web of Science: 1 Crossref: 1

Surveillance of hepatocellular carcinoma: is only ultrasound enough?

Woo Kyoung Jeong

Clin Mol Hepatol. 2017;23(3):222-223. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0046

View: 6675 Download: 163 Web of Science: 7 Crossref: 6

Liver Imaging

Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis

Ah Yeong Kim, Woo Kyoung Jeong

Clin Mol Hepatol. 2016;22(1):192-197. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.192

View: 11765 Download: 235 Web of Science: 11 Crossref: 13

Benign nodules mimicking hepatocellular carcinoma on gadoxetic acid-enhanced liver MRI

Kyoung Doo Song, Woo Kyoung Jeong

Clin Mol Hepatol. 2015;21(2):187-191. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.187

View: 8948 Download: 117 Web of Science: 10 Crossref: 10

Original Article

Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the ablation volume

Sang-Wook Shin, Woo Kyoung Jeong, Sanghyeok Lim, Yongsoo Kim, Jinoo Kim

Clin Mol Hepatol. 2015;21(1):71-79. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.71

View: 7501 Download: 105 Web of Science: 3 Crossref: 4

Review

The MR imaging diagnosis of liver diseases using gadoxetic acid: Emphasis on hepatobiliary phase

Woo Kyoung Jeong, Young Kon Kim, Kyoung Doo Song, Dongil Choi, Hyo Keun Lim

Clin Mol Hepatol. 2013;19(4):360-366. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.360

View: 10888 Download: 140 Crossref: 22

Liver Imaging

Primary hepatic lymphoma mimicking acute hepatitis

Jeong-Ah Lee, Woo Kyoung Jeong, Ji Hye Min, Jinoo Kim

Clin Mol Hepatol. 2013;19(3):320-323. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.320

View: 7188 Download: 79 Crossref: 11

Pseudocirrhosis as a complication after chemotherapy for hepatic metastasis from breast cancer

Woo Kyoung Jeong, Seo-Youn Choi, Jinoo Kim

Clin Mol Hepatol. 2013;19(2):190-194. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.190

View: 8809 Download: 118 Crossref: 23

Hepatocellular carcinoma composed of two different histologic types: imaging features on gadoxetic acid-enhanced liver MRI

Seung Hyun Kim, Woo Kyoung Jeong, Yongsoo Kim, Min Yeong Kim, Jinoo Kim, Ju Yeon Pyo, Young Ha Oh

Clin Mol Hepatol. 2013;19(1):92-96. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.92

View: 7298 Download: 76 Web of Science: 10 Crossref: 11

Hepatic inflammatory pseudotumor misinterpreted as hepatocellular carcinoma

Jae Yoon Jeong, Joo Hyun Sohn, Tae Yeob Kim, Woo Kyoung Jeong, Jinoo Kim, Ju Yeon Pyo, Young Ha Oh

Clin Mol Hepatol. 2012;18(2):239-244. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.239

View: 8185 Download: 111 Crossref: 11

MR imaging of hepatic lymphangioma

Woo Jung Choi, Woo Kyoung Jeong, Yongsoo Kim, Jinoo Kim, Ju Yeon Pyo, Young Ha Oh

Clin Mol Hepatol. 2012;18(1):101-104. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.101

View: 8271 Download: 59 Crossref: 6

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5406	MAFLD: How is it different from NAFLD?
Viewed By 5215	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5095	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4727	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Author :

Author index